LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE

LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE

Aim. To evaluate the efficacy of action of the calcium sensitizer levosimendan (LS) in patients with various grade of heart failure (HF) severity before cardiosurgery.Material and methods. LS was applied as a part of HF treatment while preparing patients for surgery in 2-4 days. Performed dose was 0...

Full description

Bibliographic Details
Main Authors:	M. A. Babaev, A. A. Eremenko, O. V. Dymova, P. V. Polyakova, S. V. Fedulova, Yu. V. Frolova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-03-01
Series:	Российский кардиологический журнал
Subjects:	heart failure levosimendan myocardial reserve left ventricle ejection fraction pulmonary artery pressure natriuretic b-type peptide
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1598

Similar Items

The effects of levosimendan on renal functions in open-heart surgery patients with a low ejection fraction
by: Süleyman Yazıcı, et al.
Published: (2021-11-01)

Evaluation of the Effectiveness of Immunosorbent-Based Hemosorption in Comprehensive Conservative Therapy of End-Stage Heart Failure Patients
by: Kateryna V. Denysiuk, et al.
Published: (2022-03-01)

Is there any difference in the therapeutic effects of Levosimendan on advanced HFrEF patients with sinus rhythm or atrial fibrillation?
by: Wenyan Wang, et al.
Published: (2023-02-01)

Comparative Assessment of the Preventive Use of Intra-Aortic Baloon Counterpulsation and Levosimendan in Patients with Coronary Heart Disease and Low Left Ventricular Ejection Fraction
by: V. A. Boboshko, et al.
Published: (2012-02-01)

Levosimendan‐induced venodilation is mediated by opening of potassium channels
by: Daniel Burkhoff, et al.
Published: (2021-12-01)

Possibilities of using levosimendan in patients with idiopathic pulmonary hypertension
by: T V Martyniuk, et al.
Published: (2012-09-01)

COMPORTAMIENTO DE LA FUNCIÓN VENTRICULAR POR ECOCARDIOGRAFÍA EN PACIENTES CON INFARTO AGUDO DE MIOCARDIO / Behavior of the ventricular function by echocardiography in patients with acute myocardial infarction
by: Leonel Hernández Cruz
Published: (2009-12-01)

HEART TRANSPLANTATION FROM DONORS WITH LEFT VENTRICULAR EJECTION FRACTION <40%
by: V. N. Poptsov, et al.
Published: (2018-06-01)

Combination of Cyclosporine A and Levosimendan Induces Cardioprotection under Acute Hyperglycemia
by: Carolin Torregroza, et al.
Published: (2021-04-01)

Brain natriuretic peptide release in acute myocardial infarction
by: Azra Durak-Nalbantić, et al.
Published: (2012-08-01)

Levosimendan as a “Bridge to Optimization” in Patients with Advanced Heart Failure with Reduced Ejection—A Single-Center Study
by: Daniele Masarone, et al.
Published: (2022-07-01)

Gamma-glutamyl transpeptidase is a promising biological marker of heart failure
by: A. M. Alieva, et al.
Published: (2022-07-01)

Use of levosimendan combined with Shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study
by: Miaomiao Li, et al.
Published: (2022-03-01)

Coronary flow reserve in patients with heart failure with preserved ejection fraction
by: A. V. Mochula, et al.
Published: (2022-03-01)

MECHANICAL AND PHARMACOLOGICAL SUPPORT OF BLOOD CIRCULATION IN SURGICAL TREATMENT OF LEFT VENTRICLE POSTINFARCTION ANEURISMS
by: V. V. Vitsukaev, et al.
Published: (2010-06-01)

Right ventricle myocardial performance index versus Simpson′s right ventricle ejection fraction in patients with isolated left ventricle anterior myocardial infarction
by: Monika Maheshwari, et al.
Published: (2013-01-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)

CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: TREATMENT IN CONDITIONS OF LIMITED EVIDENCE
by: S. G. KANORSKIĬ, et al.
Published: (2018-10-01)

Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction
by: Gabriele Tumminello, et al.
Published: (2021-10-01)

Correspondence: Predictors of Mortality in Paediatric Myocarditis
by: Anirban Mandal, et al.
Published: (2017-03-01)

Mechanistic Efficacy of Sacubitril/Valsartan in Ischemic Versus Nonischemic Heart Failure
by: Reza Mohebi, et al.
Published: (2023-04-01)

Efficacy of levosimendan vs dopamine in patients with resistant cardiac failure
by: Nino Amiranovna Dzhaiani, et al.
Published: (2011-06-01)

Trajectories of Left Ventricular Ejection Fraction After Acute Decompensation for Systolic Heart Failure: Concomitant Echocardiographic and Systemic Changes, Predictors, and Impact on Clinical Outcomes
by: Judith Albert, et al.
Published: (2021-02-01)

ENDOTHELINES AND CARDIOVASCULAR PATHOLOGY
by: A. M. Alieva, et al.
Published: (2014-11-01)

LEVOSIMENDAN FOR INTENSIVE THERAPY OF HEART FAILURE IN HEART VALVE PROSTHETICS
by: O. N. Ulitkina, et al.
Published: (2016-02-01)

Cardiac Changes in Overweight and Obese Patients
by: Alexescu Teodora Gabriela, et al.
Published: (2016-09-01)

Effect of yoga lifestyle in patients with heart failure: A randomized control trial
by: Ashish Kumar Jain, et al.
Published: (2022-01-01)

The role of Inflammatory Processes in Occurrence of Left Ventricular Failure in Patients with Chronic Kidney Disease
by: Hassan Shemirani, et al.
Published: (2017-01-01)

Effect of levosimendan infusion prior to left ventricular assist device implantation on right ventricular failure
by: Amitai Segev, et al.
Published: (2022-06-01)

Echocardiographic assessment of left atrial volume index in elderly patients with left ventricle anterior myocardial infarction
by: Monika Maheshwari, et al.
Published: (2012-01-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

Levosimendan in lung transplant recipients on VA‑ECMO
by: S. V. Zhuravel, et al.
Published: (2020-04-01)

Levosimendan. A promising future drug for refractory cardiac failure in children?
by: Supriya Kushwah, et al.
Published: (2016-04-01)

The D-SPECT SH reconstruction protocol: improved quantification of small left ventricle volumes
by: Yan Huang, et al.
Published: (2024-01-01)

Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability
by: Lance C. Visser, et al.
Published: (2019-09-01)

Inhaled levosimendan versus intravenous levosimendan in patients with pulmonary hypertension undergoing mitral valve replacement
by: Tanveer Singh Kundra, et al.
Published: (2018-01-01)

Effect of intravenous levosimendan or milrinone on left atrial pressure in patients undergoing off-pump coronary artery bypass grafting—A prospective double-blind, randomized controlled trial
by: Abhinandan Mondal, et al.
Published: (2023-01-01)

Clinical Relevance of the LVEDD and LVESD Trajectories in HF Patients With LVEF < 35%
by: Yu-Chen Chen, et al.
Published: (2022-05-01)

Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
by: Yaghoub Dabiri, et al.
Published: (2018-08-01)

Quantification of Biventricular Strains in Heart Failure With Preserved Ejection Fraction Patient Using Hyperelastic Warping Method
by: Hua Zou, et al.
Published: (2018-09-01)